Genetics of height: It may be too complex for scientists to crack the code

dna sequencing genes
[W]hen the human genome was sequenced, scientists like [Joel Hirschhorn, a geneticist at Boston Children’s Hospital and the Broad Institute] thought they could plumb that data to track all the height genes….

That effort started slowly. But now, Hirschhorn says, “For height there are about 700 variants known to affect height, each of them usually with a pretty small effect on height, usually like a millimeter or less.”

Even so, the traits [Hirschhorn] found only explain about a quarter of the inherited height factors. And, frustratingly, for most of those variants scientists have no idea what they actually do.

Hirschhorn and his colleagues are expanding their already massive study of 700,000 subjects. That approach has drawn skepticism from some scientists, who think it’s a waste of effort.

David Goldstein, a professor of genetics at Columbia University, says an expanded effort could ultimately implicate every gene in existence, and that hardly helps scientists narrow down the biological factors that contribute to height.

It’s likely scientists will never be able to figure out what these hundreds of common variants do to influence height, Goldstein says. Instead, a much better strategy is [to look] for rare variants that pack a big punch.

[The study can be found here.]

The GLP aggregated and excerpted this blog/article to reflect the diversity of news, opinion, and analysis. Read full, original post: Genetics of Height is Way Complex, It Turns Out

{{ reviewsTotal }}{{ options.labels.singularReviewCountLabel }}
{{ reviewsTotal }}{{ options.labels.pluralReviewCountLabel }}
{{ options.labels.newReviewButton }}
{{ userData.canReview.message }}

Related Articles

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Does glyphosate—the world's most heavily-used herbicide—pose serious harm to humans? Is it carcinogenic? Those issues are of both legal and ...

Most Popular

ChatGPT Image May 10, 2026, 08_16_59 PM 2
Overmedicalization? RFK Jr.’s antidepressant crackdown raises conflict questions over his fee stake in Wisner Baum, the tort firm built on suing drug makers
Picture1-5
Science Disinformation Gap: The transatlantic battle over social media and censorship
Screenshot-2026-05-08-at-3.40.33-PM
Seeds of power: China turns to genetic engineering to become global superpower
Picture1-14
When superbugs threaten vulnerable children: Can AI help solve antibiotic resistance?
ChatGPT-Image-Apr-13-2026-02_20_22-PM
Viewpoint: Misinformation infodemic? Why assessing evidence is so challenging 
S
As vaccine rejectionism spreads, measles may be taking a more dangerous turn
Screenshot 2026-05-08 at 3.01
Transforming farming and nutrition with AI and robotics? Larry Ellison’s half-billion-dollar Hawaii greenhouse dream goes bust
Screenshot-2026-05-01-at-1.29.41-PM
Viewpoint: What happens when whole grains meet modern food manufacturing? Labels don’t tell the whole story.
Farmers can talk to plants
Farmers are a major source of misinformation—about farming
ChatGPT-Image-May-8-2026-01_41_33-PM-3
Viewpoint: Surge of climate misinformation traced to right wing and anti-wind activists 
Screenshot-2026-04-20-at-2.26.27-PM
Viewpoint — Food-fear world: The latest activist scientists campaign: Cancer-causing additives
Screenshot-2026-03-13-at-12.14.04-PM
The FDA wants to make many popular prescription drugs OTC—a great idea. Here’s why it’s unlikely to happen
ChatGPT-Image-Mar-27-2026-11_47_30-AM-2
FDA’s expedited drug reviews are hailed in some quarters but other approval practices are problematic
bigstock opioids on chalkboard with rol
GLP podcast: 'Safe injection sites': enabling drug addiction or saving lives?
glp menu logo outlined

Get news on human & agricultural genetics and biotechnology delivered to your inbox.